Successful treatment of chronic Parvovirus B19 infection by high-dose immunoglobulin

2003 ◽  
Vol 59 (04) ◽  
pp. 311-312 ◽  
Author(s):  
R. Mareschal-Desandes ◽  
J.L. Andre ◽  
J.F. Lesesve ◽  
M.J. Krier ◽  
P. Bordigoni ◽  
...  
Keyword(s):  
Successful Treatment ◽  
Parvovirus B19 ◽  
High Dose ◽  
Parvovirus B19 Infection

Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin

The Lancet ◽  
1995 ◽  
Vol 345 (8950) ◽  
pp. 660-661 ◽  
Author(s):  
Anders Selbing ◽  
Ann Josefsson ◽  
LarsOlav Dahle ◽  
Richard Lindgren
Keyword(s):  
Parvovirus B19 ◽  
High Dose ◽  
Parvovirus B19 Infection ◽  
Intravenous Gammaglobulin

scholarly journals Hyaluronidase-Facilitated High-Dose Subcutaneous IgG Effectively Controls Parvovirus B19 Infection in a Pediatric Cardiac Transplant Patient With Severe T-Cell Lymphopenia

2020 ◽  
Vol 7 (5) ◽  
Author(s):  
Rachel J Cruz ◽  
Joseph F Dasso ◽  
Carla Duff ◽  
Diane Krasnopero ◽  
Zsofia Long ◽  
...  
Keyword(s):  
T Cell ◽  
Transplant Patient ◽  
Parvovirus B19 ◽  
Ivig Treatment ◽  
High Dose ◽  
Cardiac Transplant ◽  
Subcutaneous Immunoglobulin ◽  
Transplant Patients ◽  
T Cell Lymphopenia ◽  
Parvovirus B19 Infection

Abstract We treated three pediatric cardiac transplant patients with chronic parvovirus viremia with high-dose intravenous immunoglobulin (HD-IVIG). One patient with severe T-cell lymphopenia suffered recurrent viremia and aseptic meningitis, which resolved remarkably when he was switched to high-dose hyaluronidase-facilitated subcutaneous immunoglobulin (HD-SCIG-Hy). We discuss the advantages of HD-SCIG-Hy vs HD-IVIG treatment for similar cases.

Sign in / Sign up

Export Citation Format

Share Document